Description: "COVID-19 and excess mortality: an actuarial study – Camille Delbrouck, Aon Benfield, Belgium, Jennifer Alonso-García, Department of Mathematics, Université Libre de Bruxelles, Belgium, ARC Centre of Excellence in Population Ageing Research (CEPAR), UNSW Sydney, Australia Netspar, The Netherlands How did COVID-19 change the dependence structure across major causes of death – Han Li, Ph.D., Associate Professor, Centre for Actuarial Studies | Faculty of Business and Economics, The University of Melbourne, Victoria, Australia"

Description: Navigate a perspective on the process of developing estimates and projections of mortality rates, based on a Living to 100 paper by the teacher. Discover the approach and considerations an actuary (or others) can take to develop a mortality rate assumption for five time periods. It will describe techniques to estimate historical mortality rates from which to project future mortality rates.

Description: Getting people to think beyond retirement about future care needs and how they will be paid for is critical for a healthy aging plan. However, most people avoid the topic and make rushed decisions when finding long-term care services. Hear from experts in this advisory field explain what a successful plan looks like and what it takes to get people to plan ahead.

Description: ReFocus is an annual global conference for senior-level life insurance and reinsurance executives hosted jointly by ACLI and the Society of Actuaries (SOA). This event features top-notch speakers, thought-provoking sessions, and superior networking opportunities.

Description: This article contains material excerpted from a speech given on June 17, 1997 by Tom Kelly, Senior Vice President and Managing Director of LIMRA International, at a LOMA/LIMRA Strategic Issues Conference in Singapore. The article includes demographic and economic data for various countries to illustrate the potential for growth in various Asian markets.

Description: "Issues surrounding end-of-life and palliative care are not well understood and there is little research in the actuarial literature. From an actuarial perspective, however, end-of-life is important because of the significant cost to the healthcare system. Ian Duncan will discuss some of his research on the financial implications of end-of-life care, as well as the outcomes of a palliative care program. Dr. Matzo is an engaging personality with decades of experience in gerontology and palliative nursing, including training and teaching professionals in the field. Dr. Matzo focuses on educating the public on the importance and benefits of palliative care and hospice (care given in the final six months of life). In this session on “Palliative Care Public Education,” Dr. Matzo will give us an overview of the benefits of palliative care and how this knowledge empowers the individual to make important decisions about their healthcare options. Attendees will have the opportunity to discuss the role that the actuarial profession may play in this area."

Description: "Weighted compositional data analysis for modeling and forecasting life-table death counts – Han Lin Shang, Ph.D., Professor of Business Analytics and Director of Research at the Department of Actuarial Studies and Business Analytics at Macquarie Business School, Macquarie University, Sydney, Australia, Steven Haberman, PhD, Bayes Business School, City University of London, UK Compensation Effect of Mortality as a Challenge to Life Extension – Natalia S. Gavrilova, Ph.D., Leonid A. Gavrilov, Ph.D. Academic Research Centers, NORC at the University of Chicago"

Description: At the conclusion of the session, attendees will be able to understand the potential for using global population health mortality and morbidity data in actuarial contexts. Using the Global Burden of Disease project as a resource, this session will discuss how novel population health research can be used to complement and fill in the gaps of existing input data sources for actuarial analysis and modeling. Presenters will share the latest academic research on the topics of demography, life expectancy, health-adjusted life expectancy, causes of death and disability, comprehensive disease incidence and prevalence metric, measures of disease burden for patients and populations, modifiable risk factors where there are opportunities to make interventions and improve health outcomes, and disparities between and within populations. This research is globally comprehensive and comparable between different markets and disease areas. The session will cover the motivation and purpose of GBD, a brief description of the models used, and dive deep on some selected use cases in actuarial contexts. Audiences will leave with: 1. Understanding challenges and opportunities in measuring disease burden comprehensively and consistently 2. Understanding relevant health metrics, including the drivers of future mortality and morbidity 3. Ideas for applications of epidemiological research in your work

Description: General Session

Description: Explore the National Academy of Medicine’s Global Roadmap for Healthy Longevity.AARP has been a primary sponsor of the Roadmap. The Roadmap defines Healthy Longevity as when years of good health approach the biological life span, with physical, cognitive, and social functioning that enables well-being and establishes 2050 as the target year to achieve this goal globally. This Roadmap establishes five overarching principles for healthy longevity.